Pixilab
Home › Companies › Biopharma, Biotechnology, Test and Measurement › InterK Peptide Therapeutics

InterK Peptide Therapeutics

InterK Peptide Therapeutics is a biotechnology company that researches and develops peptides that modulate the immune system.

Based based in Asia-Pacific (APAC), Australasia, InterK Peptide Therapeutics works in biopharma, biotechnology, test and measurement, founded in 2002.

InterK Peptide Therapeutics is positioned in biopharma, biotechnology, test and measurement, a segment that rewards a clear, focused offering.

Its base of operations is Asia-Pacific (APAC), Australasia.

The company is listed at the Private company stage of development.

The company reports a headcount in the c_00011_00050 range.

SectorBiopharma, Biotechnology, Test and Measurement
HeadquartersAsia-Pacific (APAC), Australasia
Founded2002
Employeesc_00011_00050
StagePrivate company

Website: interk.com.au

Browse related

Emails and contact routes are reserved for registered members.
Create a free account